AEVIS VICTORIA SA announced that its subsidiary Swiss Medical Network SA has signed an amendment to extend its CHF 150 million syndicated credit facility with a consortium of nine Swiss banks, led by UBS Switzerland AG as arranger and agent. The maturity date, originally set for 25 April 2027, has been extended to 25 April 2028, with an option to extend for a further year. All other terms and conditions of the facility remain unchanged, according to the announcement distributed via NEWMEDIAWIRE.
The early extension matters because it demonstrates lender confidence in Swiss Medical Network’s operational and financial trajectory. Thanks to improved profitability and a reduction in net debt, the group has also benefited since 30 September 2026 from a 100-basis-point reduction in the applicable margin, which is linked to its net debt/EBITDA ratio. That lower margin directly reduces the cost of borrowing on the facility. “The early extension of this facility by the entire banking syndicate confirms the banks’ confidence in Swiss Medical Network’s operational and financial trajectory,” said Michel Keusch, CFO of AEVIS.
For readers and the healthcare industry, the move provides greater financing certainty for one of Switzerland’s two leading private clinic and hospital groups. Swiss Medical Network operates a nationwide network of 19 clinics and hospitals, 80 outpatient centres and 22 eye clinics, covering a comprehensive range of medical services across 16 cantons. It is also a pioneer in integrated care, promoting coordinated, patient-centred treatment through its VIVA healthcare plan and regional care networks. The extension ensures that the group’s CHF 150 million facility remains available through April 2028, with the possibility of an additional year, supporting continuity in its operations and investment capacity.
The announcement also carries implications for AEVIS VICTORIA SA, which is listed on the SIX Swiss Exchange and majority-owns Swiss Medical Network Holding. AEVIS invests in healthcare, hospitality and lifestyle, and infrastructure, with main shareholdings including Swiss Medical Network Holding SA (76.3%, directly and indirectly), MRH Switzerland AG, Infracore SA (22.6%, directly and indirectly), Swiss Hotel Properties SA and NESCENS SA. A more favorable credit margin at the clinic group level can ease pressure on the broader group’s financial profile. More information about the clinic network is available at www.swissmedical.net.
Because the facility was extended early by the entire banking syndicate, the news suggests that Swiss Medical Network’s lenders see its debt profile as stable enough to commit ahead of the original 2027 maturity. The 100-basis-point margin reduction, tied to the net debt/EBITDA ratio, also gives the market a concrete indicator of the group’s improved profitability and deleveraging since 30 September 2026. For the healthcare sector, the extension supports the financial foundation of a major private provider at a time when coordinated, patient-centred care models are expanding. The original release can be viewed on www.newmediawire.com.
